Friday, 6 February 2004 |
| 08:30
|
001
Psychopharmacology Algorithm of Mood Disorders in Asian Countries
Meeting Room 2
|
|
|
|
|
|
|
|
|
|
|
| 10:30
|
|
|
|
|
|
|
|
|
|
|
|
| 11:00
|
002
Clinical Applications of Psychiatric Genetics
Meeting Room 2
|
|
|
|
|
|
|
|
|
|
|
| 13:30
|
|
|
|
|
|
|
|
|
|
|
|
| 14:30
|
003
Novel Comprehensive Approaches to Schizophrenia Based on Vulnerability Stress Model
Meeting Room 2
|
|
|
|
|
|
|
|
|
|
|
| 16:30
|
004
Clinical Investigations
Meeting Room 2
|
|
|
|
|
|
|
|
|
|
|
| 17:30
|
|
|
|
|
|
|
|
|
|
|
|
Saturday, 7 February 2004 |
| 08:30
|
005
Recent Advances in Functional Neuroimaging in Asia
Meeting Room 2
|
|
|
|
|
|
|
|
|
|
|
| 10:30
|
|
|
|
|
|
|
|
|
|
|
|
| 11:00
|
007
Biological and Clinical Updates on Suicide
Meeting Room 2
|
|
|
|
|
|
|
|
|
|
|
| 12:00
|
|
|
|
|
|
|
|
|
|
|
|
| 14:00
|
006a
Current Topics Among Young Psychiatrists - Part 1 (The Current Biological Researches by Young Psychiatrists in Asia)
Meeting Room 2
|
|
|
|
|
|
|
|
|
|
|
| 15:40
|
006b
Current Topics Among Young Psychiatrists - Part 2 (For the Development of Biological Psychiatry in Asia)
Meeting Room 2
|
|
|
|
|
|
|
|
|
|
|
| 16:40
|
|
|
|
|
|
|
|
|
|
|
|
Monday, 9 February 2004 |
| 18:00
|
008
Official Opening
Tumbalong Auditorium
|
|
|
|
|
|
|
|
|
|
|
| 19:00
|
|
|
|
|
|
|
|
|
|
|
|
Tuesday, 10 February 2004 |
| 09:00
|
011
Schizophrenia: Not only a neurodevelopmental but also a neurodegenerative disorder?
Harbourside Auditorium 2
|
|
|
|
|
|
|
|
|
|
|
| 10:00
|
|
|
|
|
|
|
|
|
|
|
|
| 10:30
|
012
Biological Basis for Drug Treatment in Panic Disorder
Harbourside Auditorium 1
|
013
The Relevance of Neurosteroids to Psychiatry: From the Laboratory to the Bedside
Ballroom 2
|
014
Prodromal Symptoms in Schizophrenia
Tumbalong Auditorium
|
015
Neuropeptides: From Genes to Psychopathologies
Ballroom 1
|
016
Functional Imaging and the Interaction of Cognition and Emotion
Pyrmont 2
|
017
Ethical Implications of Research in Biological Psychiatry
Harbourside Meeting Room 3
|
018
Functional Hemispheric Asymmetry in Psychiatric Disorders
Harbourside Meeting Room 4
|
019
New Perspectives in Schizophrenia
Pyrmont 1
|
020
Impact of Biological, Social and Genetic Factors During Development on the Emergence of Psychosis: From Animal Models to Clinical Studies
Harbourside Room
|
009
Antipsychotic Drug Use
Promenade Meeting Room 4
|
010
Depression, Stroke and Cardiovascular Disease
Promenade Meeting Room 6
|
| 12:30
|
|
|
|
|
|
|
|
|
|
|
|
| 13:00
|
021
Bristol-Myers Squibb & Otsuka Pharmaceuticals Satellite Symposium - New Antipsychotics for the Treatment of Schizophrenia and Other Psychotic Disorders
Ballroom 2
|
022
Pfizer Satellite Symposium - Fifteen Years of SSRIs: What Have We Learned?
Tumbalong Auditorium
|
|
|
|
|
|
|
|
|
|
| 14:30
|
023
The Impact of Psychoneuroimmunology for Therapeutic Progress: Part 1
Harbourside Meeting Room 3
|
024
Research in Depression and Mood Disorders
Ballroom 1
|
025
Acute and Chronic Actions of Alcohol and Drugs of Abuse: A Search for Common Mechanisms
Pyrmont 1
|
026
Cerebral Mechanisms in Developing Psychoses
Harbourside Auditorium 1
|
027
The Impact of Psychoneuroimmunology for Therapeutic Progress: Part 2
Harbourside Room
|
028
Pharmacogenetics of Antipsychotic Treatment: Predicting Clinical Efficacy and Side Effects
Harbourside Meeting Room 4
|
029
Neurophysiological Studies in Psychopathology
Pyrmont 2
|
030
Dementia
Promenade Meeting Room 4
|
031
Anxiety and Pain
Promenade Meeting Room 6
|
|
|
| 14:45
|
032
Brain Imaging and the Pathophysiology of Bipolar Disorder
Tumbalong Auditorium
|
033
Brain Neuroimaging in Affective Disorders
Ballroom 2
|
| 16:00
|
034
Tuesday Posters - ADHD
Hall 5, Exhibition Halls
|
035
Tuesday Posters - Animal Models
Hall 5, Exhibition Halls
|
036
Tuesday Posters - Bipolar Disorder
Hall 5, Exhibition Halls
|
037
Tuesday Posters - Eating Disorders
Hall 5, Exhibition Halls
|
038
Tuesday Posters - Miscellaneous Topics
Hall 5, Exhibition Halls
|
|
|
| 16:15
|
|
|
|
|
|
| 16:45
|
|
|
|
|
|
|
| 17:00
|
039
H. Lundbeck A/S Satellite Symposium - Management of Mood and Anxiety Disorders
Harbourside Auditorium 1
|
040
GlaxoSmithKline Satellite Symposium - Stabilizing Mood from Down Under
Tumbalong Auditorium
|
041
Novartis Pharma AG Satellite Symposium - Treatment of Treatment Resistant Schizophrenia: Crossing Cultures
Ballroom 2
|
|
|
|
|
|
|
|
|
| 19:00
|
|
|
|
|
|
|
|
|
|
|
|
Wednesday, 11 February 2004 |
| 08:00
|
042
Advances in the Genetics of Schizophrenia
Tumbalong Auditorium
|
043
New Pharmacological Strategies to Treat Alcohol Problems
Ballroom 1
|
044
Recent Advances of Diagnostic Marker for Alzheimer's Disease and Related Disorders
Harbourside Auditorium 1
|
045
Clinical Questions in Bipolar Illness
Pyrmont 1
|
046
Update on Tourette's Syndrome
Pyrmont 2
|
047
Synergistic Information about Brain Function by Simultaneous EEG/fMRI: From Basics to Clinical Applications
Harbourside Meeting Room 4
|
048
Biological Markers in Depression
Ballroom 2
|
049
Praecox Diagnosis of Dementia Praecox
Harbourside Room
|
050
Critical Assessment of Biological Markers in Affective Disorders
Harbourside Meeting Room 3
|
051
Drug and Alcohol Dependence
Promenade Meeting Room 4
|
052
Cognitive Neuropsychiatry
Promenade Meeting Room 6
|
| 10:00
|
|
|
|
|
|
|
|
|
|
|
| 10:15
|
|
|
|
|
|
|
|
|
|
|
|
| 10:30
|
053
Recognition and Response in Complex Biological Systems
Harbourside Auditorium 2
|
|
|
|
|
|
|
|
|
|
|
| 11:15
|
|
|
|
|
|
|
|
|
|
|
|
| 11:30
|
054
State of the art of acute and long-term treatment of schizophrenia
Harbourside Room
|
055
ECT Practice Update
Pyrmont 1
|
056
State of the art and long-term treatment of anxiety disorders
Pyrmont 2
|
057
State of the art of acute and long-term treatment of bipolar affective disorders
Harbourside Meeting Room 3
|
058
State of the art treatment of dementia
Harbourside Meeting Room 4
|
|
|
|
|
|
|
| 12:30
|
|
|
|
|
|
|
|
|
|
|
|
| 13:00
|
059
GlaxoSmithKline Satellite Symposium - Advances in the Treatment of Mood and Anxiety Disorders
Tumbalong Auditorium
|
060
Wyeth Satellite Symposium - The Mind, Brain, Body Connection: Treating People with Depression in the 21st Century
Ballroom 2
|
134
Merck & Co., Inc. Satellite Symposium - Clinical and Functional Issues in Disease Modification of Alzheimer's Disease
Harbourside Auditorium 1
|
|
|
|
|
|
|
|
|
| 14:30
|
061
Understanding the Neurobiology of Bipolar Disorder
Pyrmont 1
|
062
The Role of GABAA Receptors in the Treatment of Panic Disorder
Harbourside Meeting Room 3
|
063
Neurobiological Vulnerability to Schizophrenia
Harbourside Auditorium 1
|
064
Psychobiology of PTSD
Ballroom 1
|
065
Imaging in Psychiatric Diseases
Pyrmont 2
|
066
Magnetic Resonance Spectroscopy in Psychiatry: Present & Future
Harbourside Room
|
068
Clinical Psychiatry
Promenade Meeting Room 4
|
069
Genetics of Psychiatric Disorders
Promenade Meeting Room 6
|
|
|
|
| 14:45
|
070
Diagnosis and Treatment of Dementia with Lewy Bodies
Ballroom 2
|
071
Genes and Neurochemistry Distinguish Suicide and Major Psychiatric Disorders
Tumbalong Auditorium
|
|
| 16:00
|
072
Wednesday Posters - Ageing / Dementia
Hall 5, Exhibition Halls
|
073
Wednesday Posters - Depression
Hall 5, Exhibition Halls
|
074
Wednesday Posters - ECT / TMS
Hall 5, Exhibition Halls
|
075
Wednesday Posters - Genetics
Hall 5, Exhibition Halls
|
076
Wednesday Posters - Neuropsychiatry / Cognitive Neuropsychiatry
Hall 5, Exhibition Halls
|
077
Wednesday Posters - PMS
Hall 5, Exhibition Halls
|
078
Wednesday Posters - Psychoimmunology / Psychoneuroendocrinology
Hall 5, Exhibition Halls
|
|
| 16:15
|
|
|
|
| 17:00
|
079
The Lilly/Boehringer Ingelheim Alliance Satellite Symposium - Dual Action Antidepressants: A New Frontier in the Treatment of Depression
Harbourside Auditorium 1
|
080
Organon Satellite Symposium - Improving Your Success in Managing Depression Up-To-Date Pharmacotherapy and Treatment Strategies
Tumbalong Auditorium
|
|
|
|
|
|
|
|
|
| 17:15
|
|
|
|
|
|
|
|
|
|
| 18:45
|
|
|
|
|
|
|
|
|
|
|
| 19:00
|
|
|
|
|
|
|
|
|
|
|
|
Thursday, 12 February 2004 |
| 08:00
|
081
Cancelled Session: Early Traumatization, Brain Abnormalities, and Cognitive Dysfunctions in Borderline Personality Disorder: Possible Association?
Harbourside Meeting Room 4
|
082
Neuropsychiatric and Psychobiological Aspects of Recreational Cannabis and Ecstasy/MDMA Use
Tumbalong Auditorium
|
083
Premenstrual Dysphoria
Ballroom 2
|
084
The Role of Culture, Genetics and Ethnicity in Pharmacotherapy: Ethnopsychopharmacology
Ballroom 1
|
085
Functional and Structural Imaging in Mild Cognitive Impairment (MCI) and Early Dementias
Pyrmont 2
|
086
Neurobiological Correlates and Predictors of Psychotherapeutic Processes
Harbourside Room
|
088
Sleep Disturbances Associated with Psychiatric Disease: From Polysomography to Brain Imaging and Beyond
Pyrmont 1
|
089
Magnetic Resonance Imaging
Promenade Meeting Room 4
|
090
Miscellaneous
Promenade Meeting Room 6
|
087
Genetics of Eating Disorders
Harbourside Meeting Room 3
|
|
| 09:00
|
|
|
| 10:00
|
|
|
|
|
|
|
|
|
|
|
| 10:30
|
091
The Growing Brain
Harbourside Auditorium 2
|
|
|
|
|
|
|
|
|
|
|
| 11:15
|
|
|
|
|
|
|
|
|
|
|
|
| 11:30
|
092
State of the art of acute and long-term treatment of anxiety disorders
Pyrmont 2
|
093
State of the art of acute and long-term treatment of bipolar affective disorders
Harbourside Meeting Room 3
|
094
State of the art treatment of dementia
Harbourside Meeting Room 4
|
095
State of the art of acute and long term treatement of unipolar depression
Pyrmont 1
|
096
Agmatine: A Novel Neurotransmitter/Neuromodulator of Relevance to Psychiatry
Harbourside Room
|
|
|
|
|
|
|
| 12:30
|
|
|
|
|
|
|
|
|
|
|
|
| 13:00
|
098
Pfizer Satellite Symposium - Future Horizons in the Treatment of Schizophrenia: Beyond Positive Symptoms
Tumbalong Auditorium
|
|
|
|
|
|
|
|
|
|
|
| 14:30
|
099
Ethanol Induced Brain Damage
Promenade Meeting Room 6
|
100
Common Mechanisms of Action between Antidepressants and Antipsychotics
Harbourside Meeting Room 4
|
101
Cholinesterase Inhibitors for Dementia Praecox and Dementia Senilis
Harbourside Meeting Room 3
|
102
Novel Pharmacological Targets For Treatment of Mood Disorders and Psychoses
Ballroom 2
|
103
Omega-3 Fatty Acids Treatment of Depression and Schizophrenia
Ballroom 1
|
104
Characterizing Addiction in Vivo with Neuroimaging
Pyrmont 1
|
105
Biological Psychiatry and Neuroscience: Tracing the Boundaries
Harbourside Auditorium 1
|
106
Cycloid Psychoses
Pyrmont 2
|
107
Treatment of Depresson: Modalities and Mechanisms
Promenade Meeting Room 4
|
|
|
| 14:45
|
108
Neurobiological Findings in Prodromal States of First-Episode Psychosis
Tumbalong Auditorium
|
|
| 16:00
|
109
Thursday Posters - Alcohol / Drug Dependence
Hall 5, Exhibition Halls
|
110
Thursday Posters - Anxiety Disorders
Hall 5, Exhibition Halls
|
111
Thursday Posters - Imaging
Hall 5, Exhibition Halls
|
112
Thursday Posters - Schizophrenia / Antipsychotics
Hall 5, Exhibition Halls
|
|
|
|
|
|
| 16:15
|
|
|
|
|
|
|
| 16:30
|
|
|
|
|
|
|
|
| 17:00
|
|
|
|
|
|
|
|
|
|
|
|
Friday, 13 February 2004 |
| 08:00
|
113
Endocannabinoids: A Novel Signaling System in Schizophrenia Research
Pyrmont 1
|
114
Environmental and Genetic Animal Models of Depression
Harbourside Auditorium 1
|
115
Evidence for Progressive Brain Structural Abnormalities in Early Psychosis
Tumbalong Auditorium
|
116
Synaptic Mechanisms in Pharmacology and Pathophysiology of Mood Disorders
Ballroom 2
|
117
Limbic System Interactions and the Pathophysiology of Schizophrenia
Ballroom 1
|
118
Twin Contributions in the Study of Pathogeneses of Psychiatric Diseases
Harbourside Room
|
119
Ageing
Harbourside Meeting Room 3
|
120
Treatment of Anxiety Disorders: An Update
Pyrmont 2
|
121
Effects of Antidepressant Therapy Strategies on Sleep and Endocrine Secretion: - New Aspects for the Neurobiological Basis of Depression and New Perspectives for the Antidepressant Treatment
Harbourside Meeting Room 4
|
|
|
| 10:00
|
|
|
|
|
|
|
|
|
|
|
|
| 10:30
|
122
Alzheimer's Disease: Testing the Aß Amyloid Theory
Harbourside Auditorium 2
|
|
|
|
|
|
|
|
|
|
|
| 11:15
|
|
|
|
|
|
|
|
|
|
|
|
| 11:30
|
123
State of the art of acute and long-term treatment of schizophrenia
Harbourside Room
|
124
State of the art of acute and long-term treatment of bipolar affective disorders
Harbourside Meeting Room 3
|
125
State of the art of acute and long-term treatment of unipolar depression
Pyrmont 1
|
127
Physical Health and Severe Mental Illness
Harbourside Meeting Room 4
|
|
|
|
|
|
|
|
| 12:30
|
|
|
|
|
|
|
|
|
|
|
|
| 14:30
|
128
Recent Research and Newest Clinical Developments in Electroconvulsive Therapy
Harbourside Room
|
129
The Role of Glutamate for the Integration of the Brain
Ballroom 2
|
130
Psychopathology of Tryptophan
Ballroom 1
|
131
Prepulse Inhibition. A Tool for Cross-species Investigations into Schizophrenia and Related Conditions
Tumbalong Auditorium
|
132
Endophenotypic Markers, Neural Networks and Genetics for Schizophrenia
Harbourside Auditorium 1
|
|
|
|
|
|
|
| 16:00
|
|
|
|
|
|
|
|
|
|
|
|